HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sarah Doss Selected Research

protein kinase C gamma (PRKCG)

4/2021Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1.
1/2021Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult-onset disorder.
8/2020Investigation of Visual System Involvement in Spinocerebellar Ataxia Type 14.
8/2015Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sarah Doss Research Topics

Disease

4Ataxia (Dyssynergia)
12/2021 - 08/2015
4Spinocerebellar Ataxias (Spinocerebellar Ataxia)
04/2021 - 08/2015
3Cerebellar Ataxia (Dysmetria)
04/2022 - 02/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
05/2017 - 10/2014
2Parkinson Disease (Parkinson's Disease)
08/2015 - 10/2014
2Cognitive Dysfunction
10/2014 - 02/2014
1Cerebellar Diseases (Cerebellar Syndrome)
01/2021
1Macular Degeneration (Age-Related Maculopathy)
07/2020
1Ganglion Cysts (Ganglion)
07/2020
1Optic Atrophy
07/2020
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
05/2017
1Friedreich Ataxia (Friedreich's Ataxia)
08/2015
1Corticobasal Degeneration
10/2014
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
10/2014
1Disease Progression
10/2014
1Primary Progressive Aphasia
10/2014
1Dementia (Dementias)
10/2014
1Nervous System Diseases (Neurological Disorders)
10/2014
1Atrophy
02/2014

Drug/Important Bio-Agent (IBA)

4protein kinase C gamma (PRKCG)IBA
04/2021 - 08/2015
2Retinaldehyde (Retinal)IBA
08/2020 - 07/2020
2AutoantibodiesIBA
10/2014 - 02/2014
2AntibodiesIBA
10/2014 - 02/2014
1Biomarkers (Surrogate Marker)IBA
04/2022
1acetylleucineIBA
12/2021
1Essential Amino AcidsIBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1Aspartic Acid (Aspartate)FDA Link
04/2021
1Glucose (Dextrose)FDA LinkGeneric
04/2021
1Inositol (Myoinositol)IBA
04/2021
1gamma-Aminobutyric Acid (GABA)IBA
04/2021
1Aminobutyrates (Aminobutyric Acid)IBA
04/2021
1Protein Kinases (Protein Kinase)IBA
08/2020
1Ataxin-1IBA
07/2020
1Proteins (Proteins, Gene)FDA Link
07/2020
1LipidsIBA
05/2017
1Glutathione (Reduced Glutathione)IBA
08/2015
1Immunoglobulin M (IgM)IBA
10/2014
1Immunoglobulin G (IgG)IBA
10/2014
1Immunoglobulin A (IgA)IBA
10/2014
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2014
1N-Methylaspartate (NMDA)IBA
10/2014
1EpitopesIBA
10/2014
1AntigensIBA
02/2014

Therapy/Procedure

1Duration of Therapy
12/2021
1Immunotherapy
10/2014